Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1CompletedA Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- Where
- Atlanta, Beverly Hills, Denver, Houston
- Age
- 12 years and over
- People
- 276 worldwide
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT04192344 - No phaseTaking peopleSurgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
- Where
- Bethesda
- Age
- 6 years and over
- People
- 400
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04557969 - Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Ann Arbor, Cincinnati, Dallas, Houston, Milwaukee, New York, Portland, Salt Lake City, St Louis
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 1/2Taking peoplePhase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
- Where
- Bethesda, Philadelphia
- Age
- 12 years to 85 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04959175 - No phaseTaking peopleCognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
- Where
- Bethesda, Los Angeles, Seattle
- Age
- 5 years and over
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05237986 - Phase 1/2Taking peopleDonor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- Where
- Bethesda
- Age
- 12 years to 120 years
- People
- 430
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05327023 - Phase 1/2Taking peopleTrial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- Where
- Bethesda
- Age
- 12 years to 120 years
- People
- 265
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05470491 - Phase 2Taking peopleA Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- People
- 100
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06057948 - Phase 2Taking peopleTarget Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
- Where
- Ann Arbor, Baltimore, Birmingham, Durham, Hackensack, Indianapolis, Memphis, Salt Lake City, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 1 year to 39 years
- People
- 30 worldwide
- Run by
- University of California, San Francisco
See details and how to joinNCT07226453 - Phase 1/2Not yet taking people in United StatesCombination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
- Where
- San Francisco
- Age
- 3 years to 39 years
- People
- 97
- Run by
- Sabine Mueller, MD, PhD
See details and how to joinNCT07389278 - Phase 2Taking peopleStudy of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
- Where
- Baltimore, San Francisco, Seattle
- Age
- 1 year to 39 years
- People
- 29
- Run by
- Sabine Mueller, MD, PhD
See details and how to joinNCT07447076 - No phaseEnrolling by invitationData Collection, Clinical Care and Interventions in CCR, NCI
- Where
- Bethesda
- Age
- 4 weeks to 120 years
- People
- 10,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00923065 - Phase 1/2Taking peopleA Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Where
- Atlanta, Aurora, Baltimore, Boston, Chicago, Columbus, Detroit, Durham, Houston, Miami, Nashville, New York, Orange, Philadelphia, Sacramento, Seattle, Stanford, St Louis, Washington D.C.
- Age
- 12 years and over
- People
- 840 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00 - No phaseTaking peopleThe Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
- Where
- Memphis
- People
- 400
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT05454618 - No phaseTaking peopleClonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
- Where
- Seattle
- People
- 2,000
- Run by
- University of Washington
See details and how to joinNCT06295965 - No phaseTaking peopleVirtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
- Where
- Atlanta, Houston
- Age
- 15 years to 39 years
- People
- 60
- Run by
- Emory University
See details and how to joinNCT06799481 - Phase 2Taking peopleTesting the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
- Where
- Ankeny, Ann Arbor, Aurora, Austin, Basking Ridge, Bellevue, Boiling Springs, Boston, Carroll, Cary, Chicago, City of Saint Peters, Clive, Columbia, Columbus, Commack, Creve Coeur, Dallas, Danville, DeKalb, Des Moines, Durham, Easley, Effingham, Fort Dodge, Fort Worth, Geneva, Glenview, Grayslake, Greenville, Greer, Harrison, Jacksonville, Kansas City, La Jolla, Lake Forest, Madera, Mattoon, Memphis, Middletown, Montvale, New York, Normal, Oak Brook, Oklahoma City, Omaha, Orland Park, Phoenix, Pittsburgh, Raleigh, Richardson, Richmond, Rochester, San Antonio, Seattle, Seneca, Shiloh, Springfield, St Louis, Uniondale, Urbana, Warrenville, Waukee
- Age
- 12 years and over
- People
- 48
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06900595 - No phaseTaking peopleHPC Offered for PRESERVE Expansion
- Where
- Birmingham, Columbus, Detroit, Duarte, Nashville
- Age
- 12 years to 80 years
- People
- 10
- Run by
- Ossium Health, Inc.
See details and how to joinNCT07145411 - Phase 1/2Taking peopleTesting the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
- Where
- Chicago, Columbia, New York, Oakland
- Age
- 1 year to 30 years
- People
- 76
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07437963 - Phase 2Not yet taking people in United StatesObesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma
- Where
- Memphis
- Age
- 12 years to 24 years
- People
- 100
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07790913 - No phaseTaking peopleFacial Expression Awareness Training to Understand and Recognize Emotions
- Where
- Philadelphia
- Age
- 6 years to 13 years
- People
- 40
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT07923370 - No phaseTaking peopleLong-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
- Where
- Bethesda
- Age
- 7 years to 80 years
- People
- 1,000
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT00106925 - No phaseTaking peoplePharmacogenetic Determinants Of Treatment Response In Children
- Where
- Memphis
- People
- 8,800
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT00730678 - No phaseTaking peopleProspective Comprehensive Molecular Analysis of Endocrine Neoplasms
- Where
- Bethesda
- Age
- 4 years and over
- People
- 2,415
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01005654 - No phaseTaking peopleGenetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
- Where
- San Antonio
- People
- 2,000
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT03160274